Donna Roy Grogan serves as Executive at C4 Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Donna Roy Grogan has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 1, 2025 involved receiving (via award) 6,740 shares valued at $14.5K.
Donna Roy Grogan currently holds 58,629 shares of C4 Therapeutics, Inc. (CCCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Donna Roy Grogan has been a net neutral trader of CCCC stock. They have purchased $0 and sold $0 worth of shares.
Donna Roy Grogan's most recent insider trade was on Oct 1, 2025, when they sold 6,740 shares at $2.15 per share.
Get notified when new Form 4 filings are submitted
| $1.51 |
| Discretionary |
| Apr 1, 2024 | CCCC | $13.7K | Award | 1,697 | $8.10 | Discretionary |
| Jan 2, 2024 | CCCC | $13.7K | Award | 2,108 | $6.52 | Discretionary |
| Oct 2, 2023 | CCCC | $13.8K | Award | 8,089 | $1.70 | Discretionary |
| Jul 3, 2023 | CCCC | $13.7K | Award | 4,858 | $2.83 | Discretionary |
| Apr 3, 2023 | CCCC | $13.8K | Award | 4,298 | $3.20 | Discretionary |
| Jan 3, 2023 | CCCC | $11.2K | Award | 1,763 | $6.38 | Discretionary |
| Oct 3, 2022 | CCCC | $7.1K | Award | 819 | $8.69 | Discretionary |